Iridium shareholders overwhelmingly approved Rocket Lab’s planned acquisition at a September 24, 2026, special meeting, with 99.6% of votes cast supporting the deal and approximately 81% of all outstanding shares represented. The agreement provides $27.00 in cash plus Rocket Lab equity determined through a collared exchange ratio, representing a notional value of $54.00 per Iridium share. Rocket Lab completed a $1.944 billion gross at-the-market equity offering of 29.3 million shares, secured lender consent to retain Iridium’s existing term loan and canceled a planned $3.6 billion bridge facility to fund the cash consideration. Completion remains subject to regulatory approvals and other customary conditions, with both companies targeting mid-2027. Rocket Lab shares rose 1.36% to $74.61 in Friday premarket trading after gaining 5% to approximately $73.61 in the prior session. Investors continue to assess the transaction’s financing, integration, valuation and loss-making risks, alongside Rocket Lab’s NITE-STAR contract position and strategic combination with Iridium’s satellite communications business.